Precision immunology player bags $110M to fund its work on 'disease signature' tests
A Massachusetts startup is walking away from its latest financing haul with over $100 million in fresh cash, thanks to an investor syndicate backing their pursuit of patient response tests.
The $110 million round for Scipher Medicine was led by Cowen Healthcare Investments, and includes existing big-name backers Northpond Ventures and Khosla Ventures — bringing Scipher’s total fundraising to $227 million.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.